Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Publication year range
1.
Eur J Nucl Med ; 24(2): 138-42, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9021110

ABSTRACT

Auxiliary liver transplantation (ALT), retaining in place the liver of the recipient, has been proposed as an alternative to liver replacement in patients with fulminant hepatic failure (FHF). Hepatobiliary scintigraphy (HS) has proved a unique tool for the separate assessment of graft and native liver function. Forty-eight HS scans were performed, following the injection of technetium-99m trimethyl-bromo-imino-diacetic acid, in six patients who underwent ALT for FHF. Quantitative parameters were derived from the time-activity curves of both the graft and the native liver. The function of the graft remained normal as long as the patients remained under immunosuppressive therapy (IST). The function of the native liver was almost completely absent in the 1st month in five patients, but it improved gradually in four of them. IST was then decreased in four patients and finally withdrawn in three. Spontaneous graft atrophy occurred in two patients and the graft was removed in two. All of the patients in whom IST was reduced had a normal global hepatic function and selective uptake (RU) >30% at that time. In ALT patients with FHF, HS can distinguish non-invasively the functional performance of both the donor and the recipient liver and its evolution with time.


Subject(s)
Hepatic Encephalopathy/diagnostic imaging , Hepatic Encephalopathy/surgery , Liver Transplantation/diagnostic imaging , Liver/diagnostic imaging , Adult , Aniline Compounds , Follow-Up Studies , Glycine , Humans , Image Processing, Computer-Assisted , Imino Acids , Immunosuppression Therapy , Liver Transplantation/methods , Organotechnetium Compounds , Radionuclide Imaging , Radiopharmaceuticals , Time Factors
2.
Ann Endocrinol (Paris) ; 57(5): 419-27, 1996.
Article in French | MEDLINE | ID: mdl-8991106

ABSTRACT

Thyroid dysfunction developed in 35 patients among a series of 300 (190 men and 110 women) treated with alpha-interferon (35/300 = 12%. No relationship was observed between the type of alpha-interferon, the dose, or hepatic response, but there were more women (24/35). Antithyroid antibody levels were frequently elevated before treatment (8/35, 23%). Hypothyroidism developed in 27 patients, 7 with clinical hypothyroidism, 10 with moderate hypothyroidism and 5 with elevated TSH only. Patients with severe symptoms and highly elevated thyroid antibodies were more prone to develop sustained or irreversible hypothyroidism (10 patients). Twelve patients recovered a normal thyroid function within a few months, but antibody levels fell more slowly. Primary hyperthyroidism of variable severity appeared in 13 patients. In 8 patients, normal thyroid function was recovered within a few weeks but thyroid antibodies remained high for at least one year. In 5 others spontaneous hypothyroidism occurred within a few weeks ("biphasic" hypothyroidism). Direct toxicity appears to be less probable than an autoimmune mechanism; elevated antithyroid antibodies were observed in only 20 patients (57%). In clinical practice, TSH levels should be regularly monitored during and after alpha-interferon therapy.


Subject(s)
Antiviral Agents/adverse effects , Antiviral Agents/therapeutic use , Hepatitis C/therapy , Hyperthyroidism/chemically induced , Hypothyroidism/chemically induced , Interferon-alpha/adverse effects , Interferon-alpha/therapeutic use , Adult , Aged , Antibodies/blood , Chronic Disease , Female , Humans , Hyperthyroidism/immunology , Hypothyroidism/immunology , Interferon Type I/adverse effects , Interferon Type I/therapeutic use , Male , Middle Aged , Peroxidase/immunology , Recombinant Proteins , Thyroglobulin/immunology
3.
Calcif Tissue Int ; 54(2): 91-5, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8012877

ABSTRACT

Measurements of the speed-of-sound (SOS) and of the broadband ultrasound attenuation (BUA) on the os calcis were recently proposed to assess osteoporotic fragility. Velocity and attenuation were measured through the heel which can be divided in three phases including hydroxyapatite, soft tissue, and fat. The aim of this study was to evaluate the influence of fat composition and heel width on SOS and BUA. This influence was determined from both in vitro investigations examining fat samples, phantoms, and cadaver heels, and in vivo ones observing adult volunteers as well as a wide sample section of healthy elderly women. Ultrasound velocities on various fat samples were significantly lower than those on distilled water (-65 m/second to -123 m/second). The excision of the surrounding soft tissue from cadaver heels made SOS steadily increase whereas the insertion of a 10 mm piece of lard in the lateral face of cadavers' and volunteers' heels os calcis lowered SOS about 30 m/second. Furthermore, a difference of SOS was estimated at 15 m/second for a 12.5% variation of the marrow fat weight. Among 334 elderly and healthy women aged 75 and over, a significant negative correlation was found between SOS and heel width (r = -0.27; P < 0.0001). On the other hand, fat composition had no significant effect on BUA measurement, and no significant relationship was found between BUA and heel width. This study demonstrates that an increase of heel width and fat thickness provides an underestimation of os calcis SOS, but has no significant effect on BUA.


Subject(s)
Adipose Tissue/diagnostic imaging , Calcaneus/diagnostic imaging , Adult , Aged , Aged, 80 and over , Calcaneus/anatomy & histology , Connective Tissue , Female , Humans , Hydroxyapatites , Male , Middle Aged , Reference Standards , Ultrasonography/methods
4.
Br J Radiol ; 66(781): 55-60, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8428252

ABSTRACT

In women with lumbar osteoarthritis, measurement of the os calcis bone mineral density (BMD) using dual-energy X-ray absorptiometry (DEXA) as an indication of vertebral fracture was evaluated. The in vivo precision of the method was 1.28%. Age- and sex-matched control curves were evaluated using a control of 193 females. The correlation between spine BMD and os calcis BMD was significant (r = 0.65, p << 0.001). For the osteoporotic women without osteoarthritis (n = 34), there was no significant difference in the spine and the os calcis Z-scores (-1.99SD and -1.83SD respectively). Whereas for osteoporotic women with osteoarthritis (n = 30) the spine Z-score was -0.49SD the os calcis Z-score was -1.92SD. The difference was significant (p < 0.001). Receiver operating characteristic (ROC) curves demonstrate the superiority of the os calcis as a measurement site over the lumbar spine, in correlation with existing crush fractures in the presence of osteoarthritis. It is concluded that when lumbar osteoarthritis occurs measurement of the os calcis BMD using DEXA is clinically useful for the estimation of bone mass.


Subject(s)
Bone Density , Calcaneus/pathology , Osteoarthritis/pathology , Osteoporosis, Postmenopausal/pathology , Spinal Fractures/pathology , Absorptiometry, Photon , Adult , Aged , Aged, 80 and over , Aging/pathology , Female , Humans , Lumbar Vertebrae/pathology , Middle Aged , Osteoarthritis/complications , Osteoporosis, Postmenopausal/complications
SELECTION OF CITATIONS
SEARCH DETAIL